Shares of Amarin (AMRN -3.5%) give back much of yesterday's pop on news that Teva Pharmaceutical...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Shares of Amarin (AMRN -3.5%) give back much of yesterday's pop on news that Teva Pharmaceutical (TEVA) and Par Pharmaceutical (PRX) lost their bid to sell the generic form of Lovaza. The stock had rocketed higher on perceptions that the court ruling would clear the way for Amarin's AMR101 to launch and price without competition from generic Lovaza products.